In March 2025, the company declared new plans for just a direct-to-consumer presenting of its Wegovy weight loss drug. The company set up a different pharmacy, known as NovoCare, which might cost consumers $499 monthly for access to the drug, a lot less than 50 % the price of the drug by way of other pharmaceutical distribution networks.[fifty thre